Atantares Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 18

Atantares General Information

Description

Developer of semiconductor-driven biotechnology designed to enable high-throughput molecular synthesis. The company's technology integrates CMOS and MEMS microelectrode arrays with microfluidics for electrochemical oligonucleotide synthesis, enabling biotechnology organizations to perform automated DNA synthesis, gene sequencing, primer synthesis, gene editing, and molecular screening at scale.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 902A, Building 4, Zhuangyan Liang'an Fenghui
  • Number 236 Chuangyuan Road, Industrial Park
  • Suzhou, Jiangsu 201800
  • China
+86 173
Primary Industry
Biotechnology
Other Industries
Application Software
Application Specific Semiconductors
Corporate Office
  • Room 902A, Building 4, Zhuangyan Liang'an Fenghui
  • Number 236 Chuangyuan Road, Industrial Park
  • Suzhou, Jiangsu 201800
  • China
+86 173

Atantares Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atantares Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series B) 15-Sep-2026 Completed Generating Revenue
10. Later Stage VC (Series A1) 20-Jan-2026 Completed Generating Revenue
9. Later Stage VC (Series A) 25-Jul-2025 Completed Generating Revenue
8. Later Stage VC (Series A) 15-Jul-2025 Completed Generating Revenue
7. Later Stage VC 28-Feb-2023 Completed Generating Revenue
6. Early Stage VC 04-May-2022 Completed Generating Revenue
5. Early Stage VC 19-Jul-2021 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2020 $50K $50K Completed Generating Revenue
2. Grant 17-Feb-2018 $4.45M Completed Startup
To view Atantares’s complete valuation and funding history, request access »

Atantares Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of semiconductor-driven biotechnology designed to enable high-throughput molecular synthesis. The company's te
Biotechnology
Suzhou, China
60 As of 2023

Paris, France
 

Emeryville, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atantares Competitors (29)

One of Atantares’s 29 competitors is DNA Script, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNA Script Venture Capital-Backed Paris, France
Ansa Biotechnologies Venture Capital-Backed Emeryville, CA
Integrated DNA Technologies Formerly PE-Backed Coralville, IA
Eurofins Genomics Blue Heron Formerly VC-backed Bothell, WA
Genewiz Formerly VC-backed South Plainfield, NJ
You’re viewing 5 of 29 competitors. Get the full list »

Atantares Patents

Atantares Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200055044-A1 Methods and systems for micro platelet function testing using an integrated miniaturized platelet function analyzer Inactive 02-Nov-2016
WO-2018085496-A2 Methods and systems for micro platelet function testing using an integrated miniaturized platelet function analyzer Inactive 02-Nov-2016
WO-2018085496-A3 Methods and systems for micro platelet function testing using an integrated miniaturized platelet function analyzer Inactive 02-Nov-2016
US-20180172663-A1 A mems thrombelastograph/viscoelasticity analyzer Inactive 15-Jun-2015
WO-2016205243-A1 A mems thrombelastograph/viscoelasticity analyzer Inactive 15-Jun-2015 G01N33/49
To view Atantares’s complete patent history, request access »

Atantares Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atantares Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Capital Management PE/Buyout Minority
Jiangsu Zhonggao Private Equity Fund Management Government Minority
Leader Venture Capital Growth/Expansion Minority
Aramco Ventures Corporate Venture Capital Minority
Suzhou Angel Fund of Funds Government Minority
You’re viewing 5 of 18 investors. Get the full list »

Atantares FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process